KalVista Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KALV and other ETFs, options, and stocks.

About KALV

KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa. 

CEO
Benjamin L. Palleiko
CEOBenjamin L. Palleiko
Employees
150
Employees150
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2004
Founded2004
Employees
150
Employees150

KALV Key Statistics

Market cap
609.51M
Market cap609.51M
Price-Earnings ratio
-3.29
Price-Earnings ratio-3.29
Dividend yield
Dividend yield
Average volume
548.98K
Average volume548.98K
High today
$12.65
High today$12.65
Low today
$11.31
Low today$11.31
Open price
$12.19
Open price$12.19
Volume
295.62K
Volume295.62K
52 Week high
$15.50
52 Week high$15.50
52 Week low
$7.30
52 Week low$7.30

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own KALV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.